This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meier, M. Articles by King, G. L Search for Related Content PubMed PubMed Citation Articles by Meier, M. Articles by King, G. L Social Bookmarking                   What's this?

Protein kinase C activation and its pharmacological inhibition in vascular disease

Research Division of Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA

George L King

Research Division of Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA

Vascular complications in diabetes mellitus are known to be associated with the activation of the protein kinase C (PKC) pathway through the de novo synthesis of diacylglycerol (DAG) from glycolytic intermediates. Specific PKC isoforms, mainly the b- and d-isoforms, have been shown to be persistently activated in diabetic mellitus. Multiple studies have reported that the activation of PKC leads to increased production of extracellular matrix and cytokines, enhances contractility, permeability and vascular cell proliferation, induces the activation of cytosolic phospholipase A₂ and inhibits the activity of Na⁺-K⁺-ATPase. These events are not only frequently observed in diabetes mellitus but are also involved in the actions of vasoactive agents or oxidative stress. Inhibition of PKC by two different kinds of PKC inhibitors - LY333531, a selective PKC-b-isoform inhibitor, and vitamin E, d-alpha-tocopheron - were able to prevent or reverse the various vascular dysfunctions in vitro and in vivo. Clinical studies using these compounds are now ongoing to evaluate the significance of DAG-PKC pathway activation in the development of vascular complications in diabetic patients.

Key Words: cardiovascular disease • diabetes mellitus • diabetic vascular complications • diacylglycerol (DAG) • protein kinase C (PKC)

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J.-K. Park, N. Ronkina, A. Hoft, C. Prohl, J. Menne, M. Gaestel, H. Haller, and M. Meier Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1844 - 1853. [Abstract] [Full Text] [PDF]

				R. R. Bansode, W. Huang, S. K. Roy, M. Mehta, and K. D. Mehta Protein Kinase C Deficiency Increases Fatty Acid Oxidation and Reduces Fat Storage J. Biol. Chem., January 4, 2008; 283(1): 231 - 236. [Abstract] [Full Text] [PDF]

				J. R. Klinger, J. D. Murray, B. Casserly, D. F. Alvarez, J. A. King, S. S. An, G. Choudhary, A. N. Owusu-Sarfo, R. Warburton, and E. O. Harrington Rottlerin causes pulmonary edema in vivo: a possible role for PKC{delta} J Appl Physiol, December 1, 2007; 103(6): 2084 - 2094. [Abstract] [Full Text] [PDF]

				M. Meier, J. Menne, J.-K. Park, and H. Haller Nailing down PKC isoform specificity in diabetic nephropathy two's company, three's a crowd Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2421 - 2425. [Full Text] [PDF]

				Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus J. Immunol., July 1, 2007; 179(1): 647 - 654. [Abstract] [Full Text] [PDF]

				M. Meier, J. Menne, J.-K. Park, M. Holtz, F. Gueler, T. Kirsch, M. Schiffer, M. Mengel, C. Lindschau, M. Leitges, et al. Deletion of Protein Kinase C-{varepsilon} Signaling Pathway Induces Glomerulosclerosis and Tubulointerstitial Fibrosis In Vivo J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1190 - 1198. [Abstract] [Full Text] [PDF]

				M. Meier, J.-K. Park, D. Overheu, T. Kirsch, C. Lindschau, F. Gueler, M. Leitges, J. Menne, and H. Haller Deletion of Protein Kinase C-{beta} Isoform In Vivo Reduces Renal Hypertrophy but Not Albuminuria in the Streptozotocin-Induced Diabetic Mouse Model Diabetes, February 1, 2007; 56(2): 346 - 354. [Abstract] [Full Text] [PDF]

				Y. Pu, M. L. Peach, S. H. Garfield, S. Wincovitch, V. E. Marquez, and P. M. Blumberg Effects on Ligand Interaction and Membrane Translocation of the Positively Charged Arginine Residues Situated along the C1 Domain Binding Cleft in the Atypical Protein Kinase C Isoforms J. Biol. Chem., November 3, 2006; 281(44): 33773 - 33788. [Abstract] [Full Text] [PDF]

				R. Kohl, S. Preiss, A. von Knethen, and B. Brune Oxidized low-density lipoprotein depletes PKC{alpha} and attenuates reactive oxygen species formation in monocytes/macrophages Cardiovasc Res, August 1, 2006; 71(3): 574 - 585. [Abstract] [Full Text] [PDF]

				Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF]

				M. Rodriguez-Lee, G. Ostergren-Lunden, B. Wallin, J. Moses, G. Bondjers, and G. Camejo Fatty Acids Cause Alterations of Human Arterial Smooth Muscle Cell Proteoglycans That Increase the Affinity for Low-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 130 - 135. [Abstract] [Full Text] [PDF]

				D. H. Korzick, J. M. Muller-Delp, P. Dougherty, C. L. Heaps, D. K. Bowles, and K. K. Krick Exaggerated coronary vasoreactivity to endothelin-1 in aged rats: Role of protein kinase C Cardiovasc Res, May 1, 2005; 66(2): 384 - 392. [Abstract] [Full Text] [PDF]

				A. Gallo, G. Ceolotto, P. Pinton, E. Iori, E. Murphy, G. A. Rutter, R. Rizzuto, A. Semplicini, and A. Avogaro Metformin Prevents Glucose-Induced Protein Kinase C-{beta}2 Activation in Human Umbilical Vein Endothelial Cells Through an Antioxidant Mechanism Diabetes, April 1, 2005; 54(4): 1123 - 1131. [Abstract] [Full Text] [PDF]

				K. Almind and C. R. Kahn Genetic Determinants of Energy Expenditure and Insulin Resistance in Diet-Induced Obesity in Mice Diabetes, December 1, 2004; 53(12): 3274 - 3285. [Abstract] [Full Text] [PDF]

				V. Thallas-Bonke, C. Lindschau, B. Rizkalla, L. A. Bach, G. Boner, M. Meier, H. Haller, M. E. Cooper, and J. M. Forbes Attenuation of Extracellular Matrix Accumulation in Diabetic Nephropathy by the Advanced Glycation End Product Cross-Link Breaker ALT-711 via a Protein Kinase C-{alpha}-Dependent Pathway Diabetes, November 1, 2004; 53(11): 2921 - 2930. [Abstract] [Full Text] [PDF]

				J. Menne, J.-K. Park, M. Boehne, M. Elger, C. Lindschau, T. Kirsch, M. Meier, F. Gueler, A. Fiebeler, F. H. Bahlmann, et al. Diminished Loss of Proteoglycans and Lack of Albuminuria in Protein Kinase C-{alpha}--Deficient Diabetic Mice Diabetes, August 1, 2004; 53(8): 2101 - 2109. [Abstract] [Full Text] [PDF]

				A. Hashigasako, M. Machide, T. Nakamura, K. Matsumoto, and T. Nakamura Bi-directional Regulation of Ser-985 Phosphorylation of c-Met via Protein Kinase C and Protein Phosphatase 2A Involves c-Met Activation and Cellular Responsiveness to Hepatocyte Growth Factor J. Biol. Chem., June 18, 2004; 279(25): 26445 - 26452. [Abstract] [Full Text] [PDF]

				A. E Millen, R. Klein, A. R Folsom, J. Stevens, M. Palta, and J. A Mares Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study Am. J. Clinical Nutrition, May 1, 2004; 79(5): 865 - 873. [Abstract] [Full Text] [PDF]

				M. M. Tickerhoof, P A. Farrell, and D. H. Korzick Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2694 - H2703. [Abstract] [Full Text] [PDF]

				H. Hua, S. Munk, H. Goldberg, I. G. Fantus, and C. I. Whiteside High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells J. Biol. Chem., September 5, 2003; 278(36): 33951 - 33962. [Abstract] [Full Text] [PDF]

				J. E. Gerich Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia Arch Intern Med, June 9, 2003; 163(11): 1306 - 1316. [Abstract] [Full Text] [PDF]

				R. Chibber, B. M. Ben-Mahmud, G. E. Mann, J. J. Zhang, and E. M. Kohner Protein Kinase C {beta}2-Dependent Phosphorylation of Core 2 GlcNAc-T Promotes Leukocyte-Endothelial Cell Adhesion: A Mechanism Underlying Capillary Occlusion in Diabetic Retinopathy Diabetes, June 1, 2003; 52(6): 1519 - 1527. [Abstract] [Full Text] [PDF]

				M. Guo, M. H. Wu, F. Korompai, and S. Y. Yuan Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes Physiol Genomics, January 15, 2003; 12(2): 139 - 146. [Abstract] [Full Text] [PDF]

				M. J. Sheetz and G. L. King Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA, November 27, 2002; 288(20): 2579 - 2588. [Abstract] [Full Text] [PDF]

				C. I. Whiteside and J. A. Dlugosz Mesangial cell protein kinase C isozyme activation in the diabetic milieu Am J Physiol Renal Physiol, June 1, 2002; 282(6): F975 - F980. [Abstract] [Full Text] [PDF]